unworthy of serious study, now finds itself the subject of some of the most exciting biomedical research today. This transformation was brought about by the realisation that cell death is the result of distinct cellular events rather than random disintegration. Although various modes of cell death exist, only the processes of necrosis and apoptosis have been described in detail. Necrosis is a passive process resulting from the destruction of critical cellular structures, whereas apoptosis requires the active participation of the cell in its own death and can be prevented by inhibitors of RNA and protein synthesis.' Recently, it has been discovered that some of the genes that control apoptosis are mutated in colorectal cancer and other tumours. This has given credence to the notion that failure of cell death is an important factor in carcinogenesis and has catapulted apoptosis into the headlines of modem cell biology.
Necrosis is characterised morphologically by cellular swelling, dilatation of mitochondria and endoplasmic reticulum, and flocculation of nuclear chromatin. Later there is rupture of plasma, nuclear and organelle membranes, which leads to the destruction of the cell. Large contiguous populations of cells undergo necrosis simultaneously and an inflammatory response is evoked. Necrosis is caused by important changes to the cellular environment such as the presence of toxins, cytolysins, hypoxia, ischaemia or large changes in temperature. It is rarely seen as a part of normal embryogenesis or differentiation. 2 Over the past decade the physicochemical correlates of these morphological changes have been defined. Particular attention has been paid to necrosis caused by reactive oxygen metabolites (hydrogen peroxide, hypochlorous acid, the superoxide anion, and the hydroxyl radical) released from granulocytes in tissue inflammation and the ischaemia/reperfusion reaction. In inflammatory bowel disease tissue damage is due mainly to the release of reactive oxygen metabolites, nitric oxide, and proteases from granulocytes, which induce necrosis in the gut epithelium. Evidence has also been found, however, for cytotoxic T cell mediated cell lysis in ulcerative colitis33 though this result awaits confirmation.34
Cytotoxic T cells release a calcium dependent pore forming protein called perforin, which polymerises and inserts into the plasma membrane resulting in the formation of small pores. These allow small ions to pass through the plasma membrane with resulting collapse of ion gradients and necrosis of the target cell by osmotic rupture. This mechanism is predominant when there is an excess of cytotoxic T cells in comparison with target cells with high concentrations of perforin. Under conditions found in vivo, however, where the ratio of cytotoxic T cells to cognate target cells is close to unity, the effects of perforin are less pronounced and cell death occurs instead via apoptosis. 35 Whether such a mechanism operates in inflammatory bowel disease is unknown.
The main importance of apoptosis in intestinal disease lies in its role in carcinogenesis and hence the promise of treatment for cancer. Colorectal cancer is now believed to result from a series of mutations of specific oncogenes and tumour suppressor genes.36 Among the function of some of these genes (c-myc, p53, and bcl-2) is the regulation of apoptosis. For example, overexpression of wild-type p53 induces apoptosis in human tumour colonic epithelial cells. 37 We have shown that radiation fails to induce apoptosis in the intestinal epithelium of mice lacking the p53 gene.38 It has been postulated that wild type p53 interacts with other genes in a signal transduction pathway that controls cell cycle arrest at the G1/S checkpoint following DNA damage, which allows time for DNA repair to take place.39 If the repair of DNA is unsuccessful then the cell may be deleted by activation of cellular events, which lead to apoptosis. Mutations of p53 cause failure of this self destruction mechanism, permitting the proliferation of malignant clones. c-myc seems to drive both cell proliferation and apoptosis. These two functions seem contradictory but Evan and coworkers have proposed this to be a failsafe mechanism to prevent the development of cancer.40 c-myc is only able to promote proliferation when apoptosis is actively inhibited, for example by bcl-2 expression. Thus deregulated c-myc expression alone is insufficient for oncogenesis without suppression of apoptosis by other independent mutations.
It is now realised that, in general, anticancer agents do not kill by necrosis but rather by causing sensitive cancer cells to commit suicide by the induction of apoptosis.41 Specific genes and proteins must be expressed before apoptosis can occur. Some cancers are not able to undergo apoptosis because the genes required for apoptosis are mutant or their protein products are incorrectly expressed. This is one reason for therapeutic resistance. In the gastrointestinal tract ionising radiation and many commonly used chemotherapeutic agents can induce apoptosis in the intestinal epithelium.42 High energy ionising radiation also causes necrosis. Like spontaneous apoptosis, chemotherapeutically induced apoptosis does not occur randomly but is focused on specific locations in the crypt. Following exposure to chemotherapeutic agents apoptosis is found in the ileal crypt at the level of the stem cell43 whereas in the colon it occurs well above the stem cell region. Potten and coworkers have proposed that this difference may explain the low incidence of small bowel cancer. In the small intestine, stem cells with oncogenic mutations are deleted by apoptosis whereas in the large intestine there is a greater chance of mutated stem cells escaping deletion as apoptosis occurs higher in the crypt.44 This difference in the tendency of small and large intestinal epithelium to undergo apoptosis can be partly explained by the expression of the anti-apoptosis gene bcl-2, which is expressed at the base of colonic crypts but is absent in the small intestine. 25 Moreover, radiation induced apoptosis is increased in crypts of bcl-2-deficient mice.25
Much more needs to be learnt about cell death in the gastrointestinal tract. 45 
